Delcath Systems Inc (DCTH)
US$ 11.72-2.25%
Price Chart
Key Statistics
Market Cap
$ 532.49M
P/E Ratio
0.00
Revenue (TTM)
$ 53.85M
Volume
469.38K
52W High
$ 16.97
52W Low
$ 6.33
Dividend Yield
0.00%
Beta
0.72
Technicals
50-Day MA
12.5461
200-Day MA
11.5298
52 Week High
16.97
52 Week Low
6.33
About DCTH
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.
Employees
96
Headquarters
New York, NY
CEO
Mr. Gerard J. Michel MBA, MS
Latest News
Delcath Systems to Participate at the Craig-Hallum 22nd Annual I - GuruFocus
1 hour ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg